Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Aug. 01, 2015	May. 02, 2015	Aug. 02, 2014	May. 03, 2014	Aug. 01, 2015	Aug. 02, 2014
Net Cash Provided by Operating Activities					$ 375	$ 446
Investing Activities:
Capital Expenditures					(358)	(349)
Proceeds from Sale of Other Assets					135
Proceeds from Sale of Equity Method Investments					85	0
Payments to Acquire Marketable Securities					(50)	0
Other Investing Activities					1	15
Net Cash Provided by (Used for) Investing Activities					(187)	(334)
Financing Activities:
Proceeds from Long-term Lines of Credit					0	5
Repayments of Long-term Lines of Credit					0	(5)
Repurchase of Common Stock					(295)	(48)
Dividends Paid	$ (146)	$ (734)	$ (99)	$ (392)	(880)	(491)
Excess Tax Benefits from Share-based Compensation					61	37
Net Financing Activities and Advances to/from Consolidated Affiliates					0	0
Proceeds from Exercise of Stock Options and Other					23	22
Payments of Financing Costs					0	(5)
Net Cash Provided by (Used for) Financing Activities					(1,091)	(485)
Effects of Exchange Rate Changes on Cash and Cash Equivalents					2	1
Net Increase (Decrease) in Cash and Cash Equivalents					(901)	(372)
Cash and Cash Equivalents, Beginning of Period		1,681		1,519	1,681	1,519
Cash and Cash Equivalents, End of Period	780		1,147		780	1,147
L Brands, Inc.
Net Cash Provided by Operating Activities					(147)	(172)
Investing Activities:
Capital Expenditures					0	0
Proceeds from Sale of Other Assets					0
Proceeds from Sale of Equity Method Investments					0
Payments to Acquire Marketable Securities					0
Other Investing Activities					0	0
Net Cash Provided by (Used for) Investing Activities					0	0
Financing Activities:
Proceeds from Long-term Lines of Credit						0
Repayments of Long-term Lines of Credit						0
Repurchase of Common Stock					(295)	(48)
Dividends Paid					(880)	(491)
Excess Tax Benefits from Share-based Compensation					0	0
Net Financing Activities and Advances to/from Consolidated Affiliates					1,299	694
Proceeds from Exercise of Stock Options and Other					23	22
Payments of Financing Costs						5
Net Cash Provided by (Used for) Financing Activities					147	172
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					0	0
Cash and Cash Equivalents, Beginning of Period		0		0	0	0
Cash and Cash Equivalents, End of Period	0		0		0	0
Guarantor Subsidiaries
Net Cash Provided by Operating Activities					481	514
Investing Activities:
Capital Expenditures					(254)	(248)
Proceeds from Sale of Other Assets					0
Proceeds from Sale of Equity Method Investments					1
Payments to Acquire Marketable Securities					50
Other Investing Activities					0	0
Net Cash Provided by (Used for) Investing Activities					(303)	(248)
Financing Activities:
Proceeds from Long-term Lines of Credit						0
Repayments of Long-term Lines of Credit						0
Repurchase of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					53	31
Net Financing Activities and Advances to/from Consolidated Affiliates					(1,240)	(730)
Proceeds from Exercise of Stock Options and Other					0	0
Payments of Financing Costs						0
Net Cash Provided by (Used for) Financing Activities					(1,187)	(699)
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					(1,009)	(433)
Cash and Cash Equivalents, Beginning of Period		1,462		1,353	1,462	1,353
Cash and Cash Equivalents, End of Period	453		920		453	920
Non- guarantor Subsidiaries
Net Cash Provided by Operating Activities					41	104
Investing Activities:
Capital Expenditures					(104)	(101)
Proceeds from Sale of Other Assets					135
Proceeds from Sale of Equity Method Investments					84
Payments to Acquire Marketable Securities					0
Other Investing Activities					1	15
Net Cash Provided by (Used for) Investing Activities					116	(86)
Financing Activities:
Proceeds from Long-term Lines of Credit						5
Repayments of Long-term Lines of Credit						5
Repurchase of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					8	6
Net Financing Activities and Advances to/from Consolidated Affiliates					(59)	36
Proceeds from Exercise of Stock Options and Other					0	0
Payments of Financing Costs						0
Net Cash Provided by (Used for) Financing Activities					(51)	42
Effects of Exchange Rate Changes on Cash and Cash Equivalents					2	1
Net Increase (Decrease) in Cash and Cash Equivalents					108	61
Cash and Cash Equivalents, Beginning of Period		219		166	219	166
Cash and Cash Equivalents, End of Period	327		227		327	227
Eliminations
Net Cash Provided by Operating Activities					0	0
Investing Activities:
Capital Expenditures					0	0
Proceeds from Sale of Other Assets					0
Proceeds from Sale of Equity Method Investments					0
Payments to Acquire Marketable Securities					0
Other Investing Activities					0	0
Net Cash Provided by (Used for) Investing Activities					0	0
Financing Activities:
Proceeds from Long-term Lines of Credit						0
Repayments of Long-term Lines of Credit						0
Repurchase of Common Stock					0	0
Dividends Paid					0	0
Excess Tax Benefits from Share-based Compensation					0	0
Net Financing Activities and Advances to/from Consolidated Affiliates					0	0
Proceeds from Exercise of Stock Options and Other					0	0
Payments of Financing Costs						0
Net Cash Provided by (Used for) Financing Activities					0	0
Effects of Exchange Rate Changes on Cash and Cash Equivalents					0	0
Net Increase (Decrease) in Cash and Cash Equivalents					0	0
Cash and Cash Equivalents, Beginning of Period		$ 0		$ 0	0	0
Cash and Cash Equivalents, End of Period	$ 0		$ 0		$ 0	$ 0